Integrated Data Analytics and Reporting (IDAR) Co Op

At Johnson & Johnson, we use technology and the power of teamwork to discover new ways to prevent and overcome the world’s the most significant healthcare challenges. Our Corporate, Consumer Health, Medical Devices, and Pharmaceutical teams leverage data, real-world insights, and creative minds to make life-changing healthcare products and medicines. We're disrupting outdated healthcare ecosystems and infusing them with transformative ideas to help people thrive throughout every stage of their lives. With a reach of more than a billion people every day, there’s no limit to the impact you can make here. Are you ready to reimagine healthcare?

Here, your career breakthroughs will change the future of health, in all the best ways. And you’ll change, too. You’ll be inspired, and you’ll inspire people across the world to change how they care for themselves and those they love. Amplify your impact. Join us!

Janssen Research and Development, L.L.C., a member of the Johnson and Johnson Family of Companies, is recruiting Co-op Associates for our Integrated Data Analytics and Reporting (IDAR) Training Academy! We are recruiting for the following function: Risk Management and Central Monitoring (RM-CM). The positions are for university students in the United States.

We are seeking highly motivated candidates to join our IDAR Academy. The Academy is a premier training program focused on developing and inspiring talent considering a career in pharmaceutical research and development. You can help advance our medicines in development at Janssen! Remote work options may be considered on a case-by-case basis and if approved by the Company.

• RM-CM leads the risk-based approach to monitoring clinical trials to help ensure protection of human subjects and the quality of clinical trial data. The RM-CM group is responsible for each detection, analysis, and mitigation of potential risks in clinical trials.  How you can make a difference:  Apply your knowledge of data science, analytical acuity, understanding of statistical concepts, and ability to learn and adapt to new technology to the monitoring of our clinical trials.